Sitokin Fırtınalı Hastaya Yaklaşım

Authors

Hüseyin Derya Dinçyürek

Synopsis

Cytokine storm is a severe hyper-inflammation condition resulting from an excessive and uncontrolled release of cytokines by the immune system, capable of affecting nearly every organ system in the organism. Cytokines, which regulate innate and adaptive immune cells, exert their effects by binding to cell surface receptors and activating intracellular signaling pathways such as JAK-STAT, NF-KB, and M-TOR. The etiology of cytokine storm includes monogenic hereditary causes like primary hemophagocytic lymphohistiocytosis (HLH), as well as pathogen-associated conditions including sepsis, EBV, CMV, HIV, HHV-8, Influenza, and SARS-CoV-2. Additionally, macrophage activation syndrome (MAS) developing during connective tissue diseases like Still's disease and systemic lupus erythematosus, alongside iatrogenic treatments such as CAR-T, blinatumomab, and rituximab, can trigger this condition. Clinically, fever is observed in all patients, and hypoalbuminemia, increased vascular permeability, edema, impaired organ perfusion, shock, and coagulopathy (DIC) may develop. Identifying the underlying etiology is critical for diagnosis and management. The therapeutic approach utilizes options tailored to the specific etiology, including antibiotics, antivirals, B/T-lymphocyte depletion, corticosteroids, JAK inhibitors, tocilizumab, anakinra, IVIG, or allogeneic stem cell transplantation, while anticoagulation therapy is evaluated unless contraindicated.

References

Yan G, Elbadawi M, Efferth T. Multiple cell death modalities and their key features (Review). World Acad Sci J. 2020:39-48. doi:10.3892/wasj.2020.40

Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277(1):61-75. doi:10.1111/imr.12534

Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255-2273. doi:10.1056/nejmra2026131

Cavaillon JM. Exotoxins and endotoxins: Inducers of inflammatory cytokines. Toxicon. 2018;149:45-53. doi:10.1016/j.toxicon.2017.10.016

Rosée P La, Horne AC, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465-2477. doi:10.1182/blood.2018894618

Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3-10. doi:10.1038/cmi.2015.74

Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science (80- ). 2020;368(6490):473-474. doi:10.1126/science.abb8925

Sinha P, Matthay MA, Calfee CS. Is a “cytokine Storm” Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152-1154. doi:10.1001/jamainternmed.2020.3313

Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi:10.1016/S0140-6736(20)30937-5

Elshazli RM, Toraih EA, Elgaml A, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020;15(8 August):1-20. doi:10.1371/journal.pone.0238160

Cheng L, Li H, Li L, et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10):1-18. doi:10.1002/jcla.23618

Retamozo S, Brito-Zerón P, Sisó-Almirall A, Flores-Chávez A, Soto-Cárdenas MJ, Ramos-Casals M. Haemophagocytic syndrome and COVID-19. Clin Rheumatol. 2021. doi:10.1007/s10067-020-05569-4

Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10(FEB):1-11. doi:10.3389/fimmu.2019.00119

Winkler U, Jensen M, Manzke O, Schulz H, Diehl V, Engert A. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood. 1999;94(7):2217-2224. doi:10.1182/blood.v94.7.2217.419k02_2217_2224

Published

May 20, 2021

License

License